Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vidutolimod (CMP-001), a CpG-A oligodeoxynucleotide and Toll-like receptor 9 (TLR9) agonist, activates plasmacytoid dendritic cells (pDCs) and induces the release of interferon alpha (IFNα), initiating a series of anti-tumor immune responses.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Vidutolimod (CMP-001), a CpG-A oligodeoxynucleotide and Toll-like receptor 9 (TLR9) agonist, activates plasmacytoid dendritic cells (pDCs) and induces the release of interferon alpha (IFNα), initiating a series of anti-tumor immune responses. |
Molecular Weight | N/A |
CAS No. | 147063-80-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vidutolimod 147063-80-7 inhibitor inhibit